iSpecimen Inc. Earnings Per Share (Basic)
iSpecimen Inc. (ISPC) reported Earnings Per Share (Basic) of -$0.98 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- iSpecimen Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.98.
- iSpecimen Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$6.66.
- iSpecimen Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.65.
- iSpecimen Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.48.
- iSpecimen Inc. earnings per share, basic for fiscal 2025 was -$2.28.
- iSpecimen Inc. earnings per share, basic for fiscal 2024 was -$17.58.
- iSpecimen Inc. earnings per share, basic for fiscal 2023 was -$24.55.
- iSpecimen Inc. earnings per share, basic for fiscal 2022 was -$1.16.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.98 10-Q · filed 2026-08-14 | -$4.18 10-Q · filed 2026-08-14 | -$2.74 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.99 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$6.66 10-Q · filed 2026-05-18 | -$1.81 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.17 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$3.18 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$1.95 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.28 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | -$0.48 10-Q · filed 2025-11-17 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.54 10-Q · filed 2025-11-17 | -$6.51 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$16.78 10-Q · filed 2026-08-14 | -$0.42 10-Q · filed 2025-08-14 | -$44.90 10-Q · filed 2026-08-14 | -$1.12 10-Q · filed 2025-08-14 | -$20.98 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$21.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2025-03-31 | -$28.55 10-Q · filed 2026-05-18 | -$0.71 10-Q · filed 2025-05-19 | -$12.96 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$14.62 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$18.42 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2024-12-31 | -$5.34 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$8.23 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$12.07 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$17.58 10-K · filed 2026-04-01 | ||||
| 2024-09-30 | -$2.10 10-Q · filed 2025-11-17 | -$5.66 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$11.30 10-Q · filed 2025-11-17 | -$17.60 derived: net income ÷ weighted average shares · filed 2025-11-17 | ||||
| 2024-06-30 | -$3.72 10-Q · filed 2025-08-14 | -$0.19 10-Q · filed 2024-08-06 | -$9.79 10-Q · filed 2025-08-14 | -$0.49 10-Q · filed 2024-08-06 | -$16.41 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$21.12 derived: net income ÷ weighted average shares · filed 2025-11-17 | ||
| 2024-03-31 | -$6.36 10-Q · filed 2025-05-19 | -$0.32 10-Q · filed 2024-05-07 | -$13.13 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$17.79 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$4.45 derived: net income ÷ weighted average shares · filed 2025-11-17 | |||
| 2023-12-31 | -$6.77 derived: net income ÷ weighted average shares · filed 2025-04-14 | -$11.43 derived: net income ÷ weighted average shares · filed 2025-04-14 | -$2.62 derived: net income ÷ weighted average shares · filed 2025-04-14 | -$24.55 10-K · filed 2025-04-14 | -$1.23 10-K · filed 2024-03-13 | |||
| 2023-09-30 | -$4.66 10-Q · filed 2024-11-07 | -$0.23 10-Q · filed 2023-11-02 | -$1.18 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$17.78 10-Q · filed 2024-11-07 | -$0.89 10-Q · filed 2023-11-02 | -$1.49 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||
| 2023-06-30 | -$0.39 10-Q · filed 2024-08-06 | -$0.66 10-Q · filed 2024-08-06 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.25 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2023-03-31 | -$0.27 10-Q · filed 2024-05-07 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.16 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2022-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$0.89 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$1.16 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$0.35 10-Q · filed 2023-11-02 | -$0.64 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$0.92 10-Q · filed 2023-11-02 | -$1.19 derived: net income ÷ weighted average shares · filed 2023-11-02 | ||||
| 2022-06-30 | -$0.30 10-Q · filed 2023-08-02 | -$0.57 10-Q · filed 2023-08-02 | -$0.84 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$1.07 derived: net income ÷ weighted average shares · filed 2023-11-02 | ||||
| 2022-03-31 | -$0.27 10-Q · filed 2023-05-04 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$0.77 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$1.19 derived: net income ÷ weighted average shares · filed 2023-11-02 | ||||
| 2021-12-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.50 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$2.09 10-K/A · filed 2023-03-30 | ||||
| 2021-09-30 | -$0.22 10-Q · filed 2022-11-08 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.17 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | -$0.87 10-Q · filed 2022-08-04 | -$4.21 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | -$4.23 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | -$4.97 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |